Student Samarth Institute of pharmacy Belhe, Pune Maharashtra, India.
World Journal of Biology Pharmacy and Health Sciences, 2025, 24(01), 508-518
Article DOI: 10.30574/wjbphs.2025.24.1.0951
Received on 22 September 2025; revised on 28 October 2025; accepted on 31 October 2025
Psoriasis is a chronic autoimmune skin disorder characterized by inflammation, scaling, and erythema. Turmeric (Curcuma longa) and Boswellia Serrata, with their potent anti-inflammatory and antioxidant properties, offer a promising approach to treating psoriasis. This review focuses on the development and preparation of a turmeric-Boswellia Serrata ethosomal cream, a novel topical formulation designed to enhance the delivery and efficacy of these herbal extracts. The ethosomal cream formulation combines the benefits of liposomes and ethanol, allowing for improved skin penetration and bioavailability of curcumin and boswellic acids. The synergistic action of these compounds may provide a multifaceted approach to managing psoriasis symptoms, including reducing inflammation, modulating immune responses, and promoting skin health. This review discusses the rationale, formulation, and potential benefits of turmeric-Boswellia Serrata ethosomal cream in the treatment of psoriasis, highlighting its potential as a natural, effective, and safe therapeutic option.
Psoriasis; Turmeric; Boswellia Serrata; Ethosomal Cream; Topical Formulation; Anti-Inflammatory; Antioxidant
Preview Article PDF
Snehal Vishwanath Moikar, Reema chandrakant Londhe, Madhavi Anandrao Sawant, Alisha Rafik Sayyad and Shrawani Kishor Choudhari. Development and preperation of turmeric –Boswellia Serrata Ethosomal cream using to treat psoriasis disease. World Journal of Biology Pharmacy and Health Sciences, 2025, 24(01), 508-518. Article DOI: https://doi.org/10.30574/wjbphs.2025.24.1.0951.